Kathryn Mahoney

Kathryn Mahoney currently serves as the Director, Clinical Scientist at Apogee Therapeutics since September 2024. Prior to this role, Kathryn held multiple positions at Invivyd, including Associate Director of Clinical Research and Principal Clinical Scientist from April 2021 to September 2024. Between May 2017 and April 2021, Kathryn worked as a Senior Clinical Scientist at Merck. Earlier experience includes roles as a Clinical Pharmacist and Pharmacy Resident at Clara Maass Medical Center from July 2013 to March 2019. Kathryn earned a Doctor of Pharmacy (PharmD) degree from Purdue University.